Indication
Pathologic myopia
Pathologic myopia, also known as degenerative myopia, is a severe ocular condition characterized by excessive, progressive axial elongation of the globe that leads to structural deformities and irreversible loss of best-corrected visual acuity. Read more about Pathologic myopia
3 drugs 3 manufacturers
Drugs that treat it
Common Pathologic myopia therapies.
VISUDYNE (verteporfin)
VISUDYNE (verteporfin)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonPathologic myopia, also known as degenerative myopia, is a severe ocular condition characterized by excessive, progressive axial elongation of the globe that leads to structural deformities and irreversible loss of best-corrected visual acuity.
Primarily affecting the posterior pole of the eye—including the sclera, choroid, and retina—in individuals with high myopia, it affects approximately one to three percent of the global population and represents a leading cause of visual impairment.
Key pathophysiologic and clinical features include posterior staphyloma, diffuse or patchy chorioretinal atrophy, lacquer cracks, and myopic traction maculopathy.
A major vision-threatening complication is the development of secondary choroidal neovascularization, which can cause macular hemorrhage, scarring, and profound central vision loss.
- nih.gov
Pathologic myopia, also known as degenerative myopia, is a severe ocular condition characterized by excessive, progressive axial elongation of the globe that leads to structural deformities and irreversible loss of best-corrected visual acuity Key pathophysiologic and clinical features include posterior staphyloma, diffuse or patchy chorioretinal atrophy, lacquer cracks, and myopic traction maculopathy
- nih.gov
Pathologic myopia, also known as degenerative myopia, is a severe ocular condition characterized by excessive, progressive axial elongation of the globe that leads to structural deformities and irreversible loss of best-corrected visual acuity Key pathophysiologic and clinical features include posterior staphyloma, diffuse or patchy chorioretinal atrophy, lacquer cracks, and myopic traction maculopathy
- nih.gov
Primarily affecting the posterior pole of the eye—including the sclera, choroid, and retina—in individuals with high myopia, it affects approximately one to three percent of the global population and represents a leading cause of visual impairment Key pathophysiologic and clinical features include posterior staphyloma, diffuse or patchy chorioretinal atrophy, lacquer cracks, and myopic traction maculopathy A major vision-threatening complication is the development of secondary choroidal neovascu...
- nih.gov
Primarily affecting the posterior pole of the eye—including the sclera, choroid, and retina—in individuals with high myopia, it affects approximately one to three percent of the global population and represents a leading cause of visual impairment
- eyesoneyecare.com
Primarily affecting the posterior pole of the eye—including the sclera, choroid, and retina—in individuals with high myopia, it affects approximately one to three percent of the global population and represents a leading cause of visual impairment
- allaboutvision.com
A major vision-threatening complication is the development of secondary choroidal neovascularization, which can cause macular hemorrhage, scarring, and profound central vision loss
Personalize your experience
Follow Pathologic myopia and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.